Eyestem raises Series A round led by three pharma majors The investment will enable Eyestem to progress a treatment for dry age-related macular degeneration to the clinic
Eyestem raises funds from global investors in Switzerland, South Africa The investment will boost Eyestem's efforts to find treatment for dry age-related macular degeneration, leading cause of incurable…
